Literature DB >> 23522584

Toric intraocular lenses: historical overview, patient selection, IOL calculation, surgical techniques, clinical outcomes, and complications.

Nienke Visser1, Noël J C Bauer, Rudy M M A Nuijts.   

Abstract

We present an overview of currently available toric intraocular lenses (IOLs) and multifocal toric IOLs. Relevant patient selection criteria, IOL calculation issues, and surgical techniques for IOL implantation are discussed. Clinical outcomes including uncorrected visual acuity, residual refractive astigmatism, and spectacle independency, which have been reported for both toric IOLs and multifocal toric IOLs, are reviewed. The incidence of misalignment, the most important complication of toric IOLs, is determined. Finally, future developments in the field of toric IOLs are discussed.
Copyright © 2013 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23522584     DOI: 10.1016/j.jcrs.2013.02.020

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  53 in total

1.  Corrective Techniques and Future Directions for Treatment of Residual Refractive Error Following Cataract Surgery.

Authors:  Majid Moshirfar; Michael V McCaughey; Luis Santiago-Caban
Journal:  Expert Rev Ophthalmol       Date:  2014-12

2.  An easy and practical method for toric intraocular lens implantation: marking corneal astigmatic axis at slit-lamp.

Authors:  Huseyin Bayramlar; Yaşar Dag; Remzi Karadag; Ozgur Cakici
Journal:  Int Ophthalmol       Date:  2016-05-12       Impact factor: 2.031

3.  [Comparison of IOL-Master 500 vs. Lenstar LS900 concerning the calculation of target refraction: A retrospective analysis].

Authors:  M Stattin; C Zehetner; N E Bechrakis; L Speicher
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

4.  Biomedicine: Visionary stem-cell therapies.

Authors:  Julie T Daniels
Journal:  Nature       Date:  2016-03-09       Impact factor: 49.962

5.  Toric IOL positioning with a no-touch head-up display axis alignment.

Authors:  J Luebke; D Boehringer; P Maier; T Reinhard; P Eberwein
Journal:  Int Ophthalmol       Date:  2019-11-23       Impact factor: 2.031

6.  Clinical outcomes of Ankoris toric intraocular lens implantation using a computer-assisted marker system.

Authors:  Biana Dubinsky-Pertzov; Idan Hecht; Inbal Gazit; Lior Or; Ori Mahler; Shlomo Rotman; Eran Pras; Adi Einan-Lifshitz
Journal:  Int Ophthalmol       Date:  2020-07-27       Impact factor: 2.031

7.  Lens regeneration using endogenous stem cells with gain of visual function.

Authors:  Haotian Lin; Hong Ouyang; Jie Zhu; Shan Huang; Zhenzhen Liu; Shuyi Chen; Guiqun Cao; Gen Li; Robert A J Signer; Yanxin Xu; Christopher Chung; Ying Zhang; Danni Lin; Sherrina Patel; Frances Wu; Huimin Cai; Jiayi Hou; Cindy Wen; Maryam Jafari; Xialin Liu; Lixia Luo; Jin Zhu; Austin Qiu; Rui Hou; Baoxin Chen; Jiangna Chen; David Granet; Christopher Heichel; Fu Shang; Xuri Li; Michal Krawczyk; Dorota Skowronska-Krawczyk; Yujuan Wang; William Shi; Daniel Chen; Zheng Zhong; Sheng Zhong; Liangfang Zhang; Shaochen Chen; Sean J Morrison; Richard L Maas; Kang Zhang; Yizhi Liu
Journal:  Nature       Date:  2016-03-09       Impact factor: 49.962

8.  Prevalence of corneal astigmatism before cataract surgery in Indian population.

Authors:  Pawan Prasher; Jasdeep Singh Sandhu
Journal:  Int Ophthalmol       Date:  2016-08-27       Impact factor: 2.031

9.  Correction of low corneal astigmatism in cataract surgery.

Authors:  Pia Leon; Marco Rocco Pastore; Andrea Zanei; Ingrid Umari; Meriem Messai; Corrado Negro; Daniele Tognetto
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

10.  Development of a program for toric intraocular lens calculation considering posterior corneal astigmatism, incision-induced posterior corneal astigmatism, and effective lens position.

Authors:  Youngsub Eom; Dongok Ryu; Dae Wook Kim; Seul Ki Yang; Jong Suk Song; Sug-Whan Kim; Hyo Myung Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.